Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |